These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12172573)

  • 1. Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD).
    Pasquale MA; Weppler D; Smith J; Icardi M; Amador A; Gonzalez M; Kato T; Tzakis A; Ruiz P
    Pathol Oncol Res; 2002; 8(2):105-8. PubMed ID: 12172573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
    Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M
    Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients.
    Niedobitek G; Mutimer DJ; Williams A; Whitehead L; Wilson P; Rooney N; Young LS; Hübscher SG
    Int J Cancer; 1997 Nov; 73(4):514-20. PubMed ID: 9389565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD30 expression and survival in posttransplant lymphoproliferative disorders.
    Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
    Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
    [No Abstract]   [Full Text] [Related]  

  • 5. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
    Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
    Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R
    Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation.
    Sekiguchi N; Nishimoto J; Tanosaki R; Kubota N; Yokota Y; Kobayashi Y; Watanabe T; Kami M; Takaue Y; Matsuno Y; Tobinai K
    Int J Hematol; 2004 May; 79(4):387-9. PubMed ID: 15218971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy.
    Wang T; Feng M; Luo C; Wan X; Pan C; Tang J; Xue F; Yin M; Lu D; Xia Q; Li B; Chen J
    Cell Transplant; 2021; 30():963689721996649. PubMed ID: 33631963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma.
    Lohrisch CA; Nevill TJ; Barnett MJ; Hogge DE; Connors JM; Keown PA; Gascoyne RD
    Leuk Lymphoma; 2000 Sep; 39(1-2):195-201. PubMed ID: 10975399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
    Pinho-Apezzato ML; Tannuri U; Tannuri AC; Mello ES; Lima F; Gibelli NE; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Andrade WC; Miyatani HT
    Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature.
    Kataoka K; Seo S; Sugawara Y; Ota S; Imai Y; Takahashi T; Fukayama M; Kokudo N; Kurokawa M
    Leuk Lymphoma; 2010 Aug; 51(8):1494-501. PubMed ID: 20578817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
    Ranganathan S; Webber S; Ahuja S; Jaffe R
    Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T; Zwick DL; Rothberg PG; Warady BA
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z; Hassan A; Pathan MH; White G
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
    Zaffiri L; Frankel C; Bush EJ; Neely ML; Pavlisko EN; Mokrova IL; Luftig MA; Palmer SM
    J Med Virol; 2021 Aug; 93(8):5040-5047. PubMed ID: 33704812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
    Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.